BTN1A1
Butyrophilin subfamily 1 member A1
Also known as: BT, BT1A1_HUMAN, BTN, BTN1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13410
- Gene
- BTN1A1
- Ensembl
- ENSG00000124557
- Chromosome
- 6
- Canonical length
- 526 aa
- Protein class
- Predicted membrane proteins
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
Butyrophilin is the major protein associated with fat droplets in the milk. It is a member of the immunoglobulin superfamily. It may have a cell surface receptor function. The human butyrophilin gene is localized in the major histocompatibility complex (MHC) class I region of 6p and may have arisen relatively recently in evolution by the shuffling of exons between 2 ancestral gene families [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
526 residues, UniProt reviewed canonical sequence.
>Q13410|BTN1A1
1 MAVFPSSGLP RCLLTLILLQ LPKLDSAPFD VIGPPEPILA VVGEDAELPC RLSPNASAEH
61 LELRWFRKKV SPAVLVHRDG REQEAEQMPE YRGRATLVQD GIAKGRVALR IRGVRVSDDG
121 EYTCFFREDG SYEEALVHLK VAALGSDPHI SMQVQENGEI CLECTSVGWY PEPQVQWRTS
181 KGEKFPSTSE SRNPDEEGLF TVAASVIIRD TSAKNVSCYI QNLLLGQEKK VEISIPASSL
241 PRLTPWIVAV AVILMVLGLL TIGSIFFTWR LYNERPRERR NEFSSKERLL EELKWKKATL
301 HAVDVTLDPD TAHPHLFLYE DSKSVRLEDS RQKLPEKTER FDSWPCVLGR ETFTSGRHYW
361 EVEVGDRTDW AIGVCRENVM KKGFDPMTPE NGFWAVELYG NGYWALTPLR TPLPLAGPPR
421 RVGIFLDYES GDISFYNMND GSDIYTFSNV TFSGPLRPFF CLWSSGKKPL TICPIADGPE
481 RVTVIANAQD LSKEIPLSPM GEDSAPRDAD TLHSKLIPTQ PSQGAPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BTN1A1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 30 nTPM
Expression across tissuesHPA
Tissue
- breast: 30 nTPM
- tonsil: 0.7 nTPM
- lymph node: 0.5 nTPM
- appendix: 0.3 nTPM
- spleen: 0.3 nTPM
- spinal cord: 0.2 nTPM
Single-cell type
- breast lactating cells: 1,363 nCPM
- cytotrophoblasts: 3.4 nCPM
- thymocytes: 3.4 nCPM
- early primary spermatocytes: 3 nCPM
- breast secretory cells: 2.6 nCPM
- epicardial cells: 2.3 nCPM
Immune cell
- memory B-cell: 2.2 nTPM
- naive B-cell: 1.9 nTPM
- non-classical monocyte: 0.6 nTPM
- eosinophil: 0.3 nTPM
- MAIT T-cell: 0.2 nTPM
- basophil: 0 nTPM
Brain region
- hippocampal formation: 0.8 nTPM
- cerebellum: 0.7 nTPM
- medulla oblongata: 0.7 nTPM
- midbrain: 0.6 nTPM
- spinal cord: 0.6 nTPM
- white matter: 0.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.09
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.32
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- B30.2/SPRY domain
- Immunoglobulin domain subtype
- SPRY domain
- Butyrophylin-like, SPRY domain
- SPRY-associated
- Immunoglobulin-like domain
- Immunoglobulin V-set domain
- Concanavalin A-like lectin/glucanase domain superfamily
- Immunoglobulin-like fold
- Immunoglobulin-like domain superfamily
- Butyrophilin subfamily 1/2, SPRY/PRY domain
- B30.2/SPRY domain superfamily
- BTN/MOG-like
- Butyrophilin subfamily 3 member A2-like, Ig-C domain
- SPRY domain
- Immunoglobulin V-set domain
- SPRY-associated domain
- Butyrophilin subfamily 3 member A2-like, Ig-C domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BTN1A1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BTN1A1 as an antibody target. Whether an autoantibody or antibody against BTN1A1 could matter depends on whether native BTN1A1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BTN1A1 is annotated as secreted, so native BTN1A1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label BTN1A1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...